Content
All Posts > Content under Healthcare
Orexigen Rises After Update On 2017 Priorities
Shining A Spotlight On Ailing Health Care ETFs
Article By:
David Fabian
Read
Thursday, January 5, 2017 5:02 AM EDT
Over the last twelve months, the Health Care Select Sector SPDR posted a total return of -2.76%. That final performance includes dividends and carries the stigma of being the only major S&P sector to finish the year in negative territory.
Immovable V. Unstoppable
Article By:
Marvin R Clark
Read
Wednesday, January 4, 2017 11:45 PM EDT
What happens when an unstoppable force meets an immovable object? The Federal Reserve released the minutes from its December meeting; that’s the meeting where the Fed raised interest rates for only the second time in a decade.
In this article: AU, AMZN, BCS, DPM, F, FCAU, GM, HMC, JNJ, KSS, M, NSANF, PSX, SHLD, TM, TSLA, VLKAF
What Does SGEN's Clinical Hold On CD33A Mean For Actinium?
Article By:
Jason Napodano
Read
Wednesday, January 4, 2017 5:35 PM EDT
The Seattle Genetic news to temporarily halt clinical work in some studies with CD33A is not a negative reflection on Actinium. It might, in fact, instead be an opportunity.
A Secure And Growing Dividend In Healthcare
Article By:
Marc Lichtenfeld
Read
Wednesday, January 4, 2017 4:56 PM EDT
Novartis has an excellent dividend-paying track record, raising its distribution every year for 19 years with no cuts.
In this article: NVS
Loxo Oncology Announces Proposed Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, January 4, 2017 4:41 PM EDT
Loxo Oncology, Inc. announced today that it intends to offer shares of its common stock in an underwritten public offering. Loxo Oncology also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock.
In this article: LOXO
Stocks Kick Off New Year With Gains
Article By:
Joshua Hayes
Read
Wednesday, January 4, 2017 5:03 AM EDT
A solid start to the year as traders rejoice push stocks higher. After Friday’s dismal performance we were looking for further consolidation and avoid further selling.
5 Best Performing S&P 500 Stocks To Buy In 2017
Article By:
Zacks Investment Research
Read
Tuesday, January 3, 2017 8:44 AM EDT
Citigroup has given a return of 14.8% last year, more than the S&P 500’s return of 9.5%. The company’s expected growth rate for the current year is 10.6%, higher than the S&P 500’s 8.7%.
A Dividend Growth Slow-Down: Evaluating Prospects And Drivers
Article By:
WisdomTree
Read
Tuesday, January 3, 2017 7:47 AM EDT
The annual screening process provides a plethora of data about how dividends for the U.S. equity markets have changed over time and presents important information about the underlying market fundamentals
